Home
Resources
Follow portfolio news
...

WuXi Biologics Ireland wins award for sustainable production of biomedicines

Published on
3/7/2025
Amended on
25/3/2026
0
minute(s)
Odyssey 2021
Wuxi Biologics
For the past 15 years, WuXi Biologics has been developing and manufacturing biologic pharmaceuticals, driven by the belief that every disease can be treated. The Chinese company, featured in the Vintage Altaroc FPCI Odyssey , draws on its 12,000 employees across Europe, Asia, and the United States. Its Irish site has just received the 2025 Award for Operational Excellence in Life Sciences at the Ireland Operational Excellence Awards. The purpose of this ceremony is to highlight organizations that have implemented practices of efficiency, innovation, continuous improvement, and rigorous budget management in their operations.
By
Antoine Orsoni
Antoine Orsoni
WuXi Biologics Ireland wins award for sustainable production of biomedicines
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
This article has been automatically translated. We apologize per inaccuracies or translation errors.

WuXi Biologics Ireland has integrated sustainability principles into its day-to-day operations, and has just received the Operational Excellence Award.

The site runs on 100% renewable electricity, and its new rainwater recovery systems have collected over 1,100 m³ of water for reuse (equivalent to the average annual water consumption of 7 to 10 European households). Motion-sensing LED lighting, building management systems and passive daylighting help reduce the site's energy consumption. Back-up power is provided by biofuel-powered generators, reducing potential emissions by 30%. A car-sharing program has also been launched to reduce greenhouse gas emissions, and 31 new electric vehicle charging stations have been installed on campus.

‍"We are deeply honored to receive this distinction. Thanks to its solid foundations in operational excellence and sustainability, our Irish site is establishing itself as a benchmark biopharmaceutical production hub, illustrating Ireland's industrial strengths for international partners, and serving as a model for the future of global biomedical manufacturing," boasts Dr Chris Chen, CEO of the Chinese firm.

The award received for the Irish site is not the first to crown the head of the Chinese company, already rewarded for its positive impact on the environment. WuXi Biologics is currently running several hundred projects, and has achieved a 99% success rate in over 300 large-scale production campaigns, symbolizing the quality and relevance of the drugs it develops.

Other episodes on this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
No articles in this category yet.
No items found.
Europe
Healthcare
Welcome to Altaroc
To provide you with a tailored experience, please complete your profile.
Your profile
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.